Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 3/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 2/20 | 0.36 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6388790 | 0.78 | TAAR1 (0.39) | TAAR1RIPK1HTR2ASLC6A3SLC6A2 | |
| SCHEMBL1059509 | 0.76 | EDNRB (0.42) | LMNAHTR2ASLC6A3POLBSLC6A2 | |
| SCHEMBL1059507 | 0.76 | EDNRB (0.42) | LMNAHTR2ASLC6A3POLBSLC6A2 | |
| SCHEMBL3951516 | 0.74 | TAAR1 (0.37) | TAAR1RIPK1HTR2ASLC6A3SLC6A2 | |
| SCHEMBL53374 | 0.74 | TAAR1 (0.37) | TAAR1RIPK1HTR2ASLC6A3SLC6A2 | |
| SCHEMBL3526378 | 0.74 | F2 (0.39) | TAAR1RIPK1HTR2ASLC6A3SLC6A2 | |
| SCHEMBL7605011 | 0.73 | RIPK1 (0.41) | TAAR1LMNAMMP8RIPK1SLC6A3 | |
| SCHEMBL11770112 | 0.72 | TAAR1 (0.40) | TAAR1LMNARIPK1HTR2ASLC6A3 | |
| SCHEMBL9493203 | 0.71 | LMNA (0.43) | TAAR1LMNARIPK1HTR2ASLC6A3 | |
| SCHEMBL708398 | 0.71 | LMNA (0.39) | LMNAMMP8RIPK1HTR2ASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030199531-A1 | YIGSR peptidomimetics and methods for using the same | UNITED STATES GOVERNMENT SECRETARY OF THE ARMY ARMY MEDICAL RESEARCH AND MATERIEL COMMAND | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199531-A1 | YIGSR peptidomimetics and methods for using the same | PNISR, SRRM2, ARGLU1 | TAAR1 1354/4885LMNA 736/4885MMP8 2027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.